(Q43293811)

English

A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma.

scientific article published on 11 August 2009

Statements

A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma. (English)
Jeffrey Weber
John A Thompson
Omid Hamid
David Minor
Asim Amin
Ilan Ron
Ruggero Ridolfi
Hazem Assi
Anthony Maraveyas
David Berman
Jonathan Siegel
Steven J O'Day
11 August 2009
5591-5598

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit